Home - Pharmaceutical Markets

Tuesday, March 9, 2010 > Home

Industry Sectors

Nabi says closes $500M licence deal with GSK

Nabi said on Monday that it has closed an option and licence agreement for the smoking vaccine candidate NicVAx with GSK, AP reports. [FULL STORY]
GSK plans to increase drug sales to middle-income countries

GSK plans to bolster earnings by selling to more people in middle-income countries after cutting prices in the world's poorest nations, Bloomberg reports. [FULL STORY]
Watson says it seeks approval for generic Opana ER

Watson said on Monday that it is seeking clearance to sell a generic version of Endo's painkiller Opana ER, AP reports. [FULL STORY]
AstraZeneca considers response to UK body on ethics code breach

AstraZeneca said on Tuesday that it is considering how to respond to a ruling by a British regulatory panel that found the drug maker failed to accurately reflect side-effects of its key antipsychotic medicine Seroquel in an advertisement to doctors, Dow Jones reports. [FULL STORY]
AstraZeneca takes Sun Pharma to court

AstraZeneca has taken Sun Pharma to court in a bid to prevent the Indian company from selling a generic form of the ulcer medicine Nexium IV in the US before 2014, the Times of India Reports. [FULL STORY]